Sunflower Pharmaceutical Group (002737)

Sunflower Pharmaceutical Group (002737)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


SUNFLOWER PHARMACEUTICAL GROUP CO.,LTD is a China-based company principally engaged in the research, development, manufacture and sale of Chinese patent drugs, chemical drugs, biopharmaceuticals and health products. The Company provides drugs in six categories, including digestive medicine, pediatric medicine, gynecological medicine, rheumatoid bone medication, breathing cold medication and cardiovascular drugs. The Company?s main products include Weikangling capsules, liver tablets, hyperactivity cough oral liquid for children use, pediatric Huatanzhike particles, Kangfu anti-inflammatory suppository and pediatric paracetamol particles, among others. The Company distributes its products in domestic market.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner